Αποτελέσματα Αναζήτησης
1 Απρ 2020 · In this review article, we highlight the current standards of care in cancer immunotherapy, with a strong focus on immune checkpoint inhibitors (ici s), their limitations and pitfalls, and promising novel approaches.
10 Ιουν 2021 · Although several pooled analyses showed that, when a cut-off of 1% was used, patients bearing a PD-L1-positive cancer had a better overall response rate to anti-PD-L1 monoclonal antibodies ...
20 Μαΐ 2020 · T cells play a central role in immune responses to cancer. In this guide to cancer immunotherapy, the authors provide a comprehensive historical and biological perspective on cancer...
1 Ιουλ 2020 · The success of cancer immunotherapy, such as ACT and ICI therapies, has demonstrated that immune cells, particularly T cells, can be harnessed to eliminate tumor cells.
20 Μαΐ 2024 · Various modes of immunotherapy—including monoclonal antibodies, immune checkpoint inhibitors, cancer vaccines, adoptive T-cell therapies, and oncolytic viruses—have achieved considerable success in clinical trials and patient results.
1 Απρ 2020 · Cancer immunotherapy is an innovative treatment for tumors today. In various experiments and clinical studies, it has been found that immunotherapy does have incomparable advantages over traditional anti-tumor therapy, which can prolong progression-free survival (PFS) and overall survival (OS).
21 Φεβ 2023 · Several possible therapeutic options are available for advanced-stage lung cancer patients, from single-agent immunotherapy to quadruple therapy, which combines immunotherapy with chemotherapy and anti-vascular endothelial growth factor medications.
